Investigational Drug Information for Resminostat
✉ Email this page to a colleague
What is the development status for investigational drug Resminostat?
Resminostat is an investigational drug.
There have been 6 clinical trials for Resminostat.
The most recent clinical trial was a Phase 2 trial, which was initiated on December 1st 2009.
The most common disease conditions in clinical trials are Carcinoma, Lymphoma, T-Cell, Cutaneous, and Sezary Syndrome. The leading clinical trial sponsors are 4SC AG, Yakult Honsha Co., LTD, and [disabled in preview].
Summary for Resminostat
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 354 |
| WIPO Patent Applications | 322 |
| Japanese Patent Applications | 111 |
| Clinical Trial Progress | Phase 2 (2009-12-01) |
| Vendors | 37 |
Recent Clinical Trials for Resminostat
| Title | Sponsor | Phase |
|---|---|---|
| A Phase 1, Open-label Study of the Absorption, Metabolism, Excretion of [14C]-Resminostat | 4SC AG | Phase 1 |
| Resminostat for Maintenance Treatment of Patients With Advanced Stage Mycosis Fungoides (MF) or Sézary Syndrome (SS) | 4SC AG | Phase 2 |
| Resminostat (YHI-1001) in Combination With Sorafenib in Asian Patients With Advanced Hepatocellular Carcinoma (HCC) | Yakult Honsha Co., LTD | Phase 1/Phase 2 |
Clinical Trial Summary for Resminostat
Top disease conditions for Resminostat
Top clinical trial sponsors for Resminostat
US Patents for Resminostat
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
